Key Pharmaceutical Regulation Issues for the New Administration
· 43 min · S1 E1
Episode Key Pharmaceutical Regulation Issues for the New Administration
In our first episode, Shelly and Wayne chat with Nikki Reeves, Partner in the FDA & Life Sciences practice at King & Spalding, and Brian Malkin, Associate General Counsel for Regulatory Law at Teva Pharmaceuticals. You'll hear their thoughts on the top priorities in pharmaceutical regulation for the next FDA commissioner and their insights on AI policy, patient voices, and other front-burner issues.
In our headlines segment, Shelly and Wayne delve into these major developments:
Pharma: More than 200,000 Prescriptions for Wegovy Filled
Devices: FDA Announces Communication Pilot on Recalls
Food: Fruits & Vegetables: Are They Really Safe?
Cosmetics: FDA Issue Final Rule on Color Additive Certification Fees
In our Resource Links segment, we listed key documents in our fore core areas. To view these links, subscribe, or find out more information about our podcast, visit FDAWatch.net.
Want to be a sponsor, marketing partner, or guest, or provide feedback on the podcast? Email us at info@FDAWatch.net.
Music by Dvir Silver from Pixabay.
Links in the notes 3
Shows are listed from Apple Podcasts' charts and directory, and Podcast Index where it is used. Every show and episode belongs to its publisher and plays from the publisher's own feed; this site hosts none of them. Explicit shows are for adult profiles only, and children’s profiles hear only children’s shows. More about this list.